Kay HE - Search Results

1

Linguistic Differences Based on Gender and Race in Urology Application Personal Statements: A Comparison of 2017 and 2023 Applications.

Bethel EC, Matthew-Onabanjo AN, Kay HE, Basak R, Demzik A, Filippou P, Viprakasit D, Borawski KM, Wallen EM, Smith AB, Tan HJ. Bethel EC, et al. Among authors: kay he. Urol Clin North Am. 2023 Nov;50(4):531-539. doi: 10.1016/j.ucl.2023.06.013. Epub 2023 Aug 12. Urol Clin North Am. 2023. PMID: 37775212 Review.

2

Comparison of Cost and Perioperative Outcomes Among Patients Undergoing Simple Prostatectomy and Laser Enucleation of the Prostate.

Hawken SR, French W, Kay H, Scales CD, Viprakasit DP, Friedlander DF. Hawken SR, et al. J Endourol. 2023 Jan;37(1):60-66. doi: 10.1089/end.2022.0404. Epub 2022 Nov 21. J Endourol. 2023. PMID: 36193580

3

Bladder Cancer Survivors Who Do Not Smoke Have Better Longitudinal Health-Related Quality of Life Measures: An Assessment of the Comparative Effectiveness and Survivorship Health in Bladder Cancer (CEASE-BC) Study.

Kay H, Silver SN, Smith AB, Basak R, Shoenbill K, Usinger D, Goldstein AO, Matulewicz RS, Chen R, Bjurlin MA. Kay H, et al. J Urol. 2024 Jul;212(1):87-94. doi: 10.1097/JU.0000000000003964. Epub 2024 Apr 11. J Urol. 2024. PMID: 38603576

4

Can genitourinary cancer survivors understand quality of life (QoL) questionnaires? Assessing the readability of commonly used urologic oncology QoL instruments.

Kay H, Rose TL, Milowsky MI, Smith AB, Bjurlin MA. Kay H, et al. Int J Urol. 2024 Sep;31(9):1061-1062. doi: 10.1111/iju.15501. Epub 2024 May 29. Int J Urol. 2024. PMID: 38808480 No abstract available.

5

Efficacy of Inpatient, Evidence-Based Tobacco Use Treatment of Patients With Bladder Cancer After Radical Cystectomy.

Trivedi H, Kay H, Reines K, Hartzell J, Newcomer E, Myers S, Matulewicz RS, Goldstein AO, Shoenbill KA, Bjurlin MA. Trivedi H, et al. Clin Genitourin Cancer. 2025 Feb;23(1):102252. doi: 10.1016/j.clgc.2024.102252. Epub 2024 Oct 28. Clin Genitourin Cancer. 2025. PMID: 39577125

6

Clearing the Smoke: Underreporting of Smoking Status in Food and Drug Administration-Approved Bladder Cancer Therapeutic Trials.

Kay H, Matulewicz RS, Bjurlin MA. Kay H, et al. J Urol. 2024 Apr;211(4):611-613. doi: 10.1097/JU.0000000000003853. Epub 2024 Feb 1. J Urol. 2024. PMID: 38299550 No abstract available.

7

Patterns of Smoking Cessation Strategies and Perception of E-cigarette Harm Among Bladder Cancer Survivors.

Chandi J, Soundararajan S, Bukowski W, Britt W, Weiss K, Matulewicz RS, Kay H, Goldstein AO, Shoenbill KA, Bjurlin MA. Chandi J, et al. Bladder Cancer. 2024;10(1):61-69. doi: 10.3233/BLC-230093. Epub 2024 Mar 12. Bladder Cancer. 2024. PMID: 38911483 Free PMC article.

8

Electronic cigarette, or vaping, product use-associated lung injury (EVALI) in a patient with testicular cancer: A case report.

Stein J, Kay HE, Sites J, Pirzadeh A, Joyner BL Jr, Darville T, Bjurlin MA, Rose TL, Jaspers I, Milowsky MI. Stein J, et al. Among authors: kay he. Tumori. 2023 Dec;109(6):NP11-NP13. doi: 10.1177/03008916231172806. Epub 2023 May 10. Tumori. 2023. PMID: 37165581 Free PMC article.

9

Preoperative and intraoperative factors predictive of complications and stricture recurrence following multiple urethroplasty techniques.

Kay HE, Srikanth P, Srivastava AV, Tijerina AN, Patel VR, Hauser N, Laviana AA, Wolf JS Jr, Osterberg EC. Kay HE, et al. BJUI Compass. 2021 Mar 10;2(4):286-291. doi: 10.1002/bco2.83. eCollection 2021 Jul. BJUI Compass. 2021. PMID: 35475301 Free PMC article.

10

Deconstructing Bias.

Kay HE. Kay HE. Acad Med. 2020 Sep;95(9):1295. doi: 10.1097/ACM.0000000000003263. Acad Med. 2020. PMID: 32134777 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters